Haleon plc
HLN
Classifica tra le azioni
#13618
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Prezzo delle azioni
$5.14
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$452.02M
Variazione (1 giorno)
1.07%
Variazione (1 anno)
9.12%
Paese
GB
Scambia Haleon plc (HLN)
Categoria
Healthcare
Storico del rendimento da dividendi per Haleon plc (HLN)
Il rendimento da dividendi (TTM) di Haleon plc (simbolo azionario: HLN) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Haleon plc (HLN) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| Non abbastanza dati per le date fornite. | ||
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
